QT Imaging signs exclusive UAE distribution agreement

QT Imaging Holdings ( (QTIH) ) has issued an announcement.

On January 19, 2026, QT Imaging Holdings entered into a three-year exclusive distribution agreement with Al Naghi Medical Co. granting the UAE-based distributor exclusive rights to market, sell and support QT Imaging’s Breast Acoustic CT scanners and QTI Cloud Platform subscriptions across the United Arab Emirates, with shipments of scanners scheduled to begin in the second quarter of 2026. The deal, which sets minimum orders totaling 43 scanners between 2026 and 2028 and is expected to generate more than $24 million in revenue, extends QT Imaging’s Middle East expansion following a recent Saudi Arabia agreement and positions the company to tap rising breast cancer screening needs in the UAE by offering a non-invasive, radiation-free imaging option tailored to a younger patient demographic, while Al Naghi assumes responsibility for regulatory clearances, logistics and local market penetration.

The most recent analyst rating on (QTIH) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Spark’s Take on QTIH Stock

According to Spark, TipRanks’ AI Analyst, QTIH is a Neutral.

The score is held down primarily by very weak financial performance (deep losses, negative equity, and sustained cash burn). Technicals are also soft with price below key short/intermediate moving averages and negative MACD. Corporate actions (PIPE financing and debt repayment, Nasdaq relisting steps) provide some offset by improving liquidity and potential market access, but valuation remains difficult to justify while the company is unprofitable.

To see Spark’s full report on QTIH stock, click here.

More about QT Imaging Holdings

QT Imaging Holdings, Inc. (OTCQB: QTIH) is a public medical device company focused on the research, development and commercialization of innovative body imaging systems that use low-frequency sound waves. Its lead product is the U.S. FDA‑cleared QTI Breast Acoustic CT scanner, a non‑invasive, radiation‑free 3D breast imaging technology, complemented by the QTI Cloud Platform, a SaaS-based imaging intelligence and decision-support ecosystem aimed at making medical imaging safer, more affordable and more accessible worldwide.

Average Trading Volume: 24,820

Technical Sentiment Signal: Buy

Current Market Cap: $68.44M

See more data about QTIH stock on TipRanks’ Stock Analysis page.